Back to Search
Start Over
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial.
- Source :
-
Journal of translational medicine [J Transl Med] 2021 Mar 29; Vol. 19 (1), pp. 128. Date of Electronic Publication: 2021 Mar 29. - Publication Year :
- 2021
-
Abstract
- Background: Omega-3 polyunsaturated fatty acids (n3-PUFAs) may exert beneficial effects on the immune system of patients with viral infections. This paper aimed to examine the effect of n3-PUFA supplementation on inflammatory and biochemical markers in critically ill patients with COVID-19.<br />Methods: A double-blind, randomized clinical trial study was conducted on 128 critically ill patients infected with COVID-19 who were randomly assigned to the intervention (fortified formula with n3-PUFA) (n = 42) and control (n = 86) groups. Data on 1 month survival rate, blood glucose, sodium (Na), potassium (K), blood urea nitrogen (BUN), creatinine (Cr), albumin, hematocrit (HCT), calcium (Ca), phosphorus (P), mean arterial pressure (MAP), O <subscript>2</subscript> saturation (O <subscript>2</subscript> sat), arterial pH, partial pressure of oxygen (PO <subscript>2</subscript> ), partial pressure of carbon dioxide (PCO <subscript>2</subscript> ), bicarbonate (HCO <subscript>3</subscript> ), base excess (Be), white blood cells (WBCs), Glasgow Coma Scale (GCS), hemoglobin (Hb), platelet (Plt), and the partial thromboplastin time (PTT) were collected at baseline and after 14 days of the intervention.<br />Results: The intervention group had significantly higher 1-month survival rate and higher levels of arterial pH, HCO <subscript>3</subscript> , and Be and lower levels of BUN, Cr, and K compared with the control group after intervention (all P < 0.05). There were no significant differences between blood glucose, Na, HCT, Ca, P, MAP, O2sat, PO <subscript>2</subscript> , PCO <subscript>2</subscript> , WBCs, GCS, Hb, Plt, PTT, and albumin between two groups.<br />Conclusion: Omega-3 supplementation improved the levels of several parameters of respiratory and renal function in critically ill patients with COVID-19. Further clinical studies are warranted. Trial registry Name of the registry: This study was registered in the Iranian Registry of Clinical Trials (IRCT); Trial registration number: IRCT20151226025699N3; Date of registration: 2020.5.20; URL of trial registry record: https://en.irct.ir/trial/48213.
- Subjects :
- Adult
Aged
Aged, 80 and over
Biomarkers analysis
Biomarkers blood
Blood Gas Analysis
Blood Glucose drug effects
Blood Glucose metabolism
COVID-19 mortality
COVID-19 physiopathology
Critical Illness mortality
Dietary Supplements
Double-Blind Method
Fatty Acids, Omega-3 administration & dosage
Female
Hematocrit
Humans
Inflammation Mediators analysis
Inflammation Mediators blood
Iran epidemiology
Kidney drug effects
Kidney physiopathology
Kidney virology
Male
Middle Aged
Mortality
Prognosis
Respiratory System drug effects
Respiratory System physiopathology
Respiratory System virology
SARS-CoV-2 drug effects
Survival Analysis
Treatment Outcome
COVID-19 diagnosis
COVID-19 diet therapy
Critical Illness therapy
Fatty Acids, Omega-3 pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1479-5876
- Volume :
- 19
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of translational medicine
- Publication Type :
- Academic Journal
- Accession number :
- 33781275
- Full Text :
- https://doi.org/10.1186/s12967-021-02795-5